British pharmaceutical company, AstraZeneca to roll out vaccines by end of September if the trials prove successful. It has partnered with Oxford University. The company has also entered in agreement with CEPI, Gavi the Vaccine Alliance, and the Serum Institute of India to double production capacity of the COVID-19 vaccine to two billion doses.
“So far we’re still on track… we are starting to manufacture this vaccine right now, and we have to have it ready to be used by the time we have the results,” AstraZeneca chief executive Pascal Soriot told BBC radio.
“Our present assumption is that we will have the data by the end of the summer, by August, so in September we should know whether we have an effective vaccine or not.”
The partnership with the Indian institute will aid in supplying to many low- and middle-income countries.
Soriot also said that the company had established different supply chains for Europe ,US , India and were also looking to establish in China.